AI Insight
Chronic obstructive pulmonary disease (COPD) continues to be a major global cause of illness and death, with its burden increasing due to aging populations, ongoing harmful exposures, and significant health disparities. This review from the Lancet Commission on COPD reassesses the 2022 vision for disease elimination through prevention, early detection, and intervention strategies. The article advocates for a comprehensive lifelong approach to lung health to address the persistent and growing challenge of COPD worldwide.
Why it matters
This update highlights the need for urgent action on COPD prevention and management, particularly as the disease burden grows with global demographic changes. The shift toward emphasizing lifelong lung health rather than just disease treatment could reshape public health policies and clinical approaches to respiratory diseases.
Understand the Science
Chronic obstructive pulmonary disease (COPD) remains a leading cause of morbidity and mortality worldwide, with increasing global burden driven by population growth and ageing, persistent harmful exposures, and substantial health inequities. The Lancet Commission on COPD articulated an ambitious vision for disease elimination with prevention, early detection, and intervention. This Review revisits that vision, assesses progress since 2022, and calls for a broader commitment to lifelong lung health as an update of the Commission.